Recruiting NA INTERVENTIONAL 2-arm NCT03127631

A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICALPC)

The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)

Sponsor: Canadian Cancer Society (CCS)

Conditions Cardiovascular Disease Prostate Cancer

Interventions ACE inhibitor Exercise Nutrition Smoking cessation Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)

Updated 13 times since 2017 Last updated: Jan 29, 2025 Started: Oct 21, 2015 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03127631, this NA trial focuses on Cardiovascular Disease and Prostate Cancer and remains actively recruiting participants. Sponsored by Canadian Cancer Society (CCS), it has been updated 13 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

13 versions recorded

Nov 2025 — Present [monthly]

Recruiting NA
Sep 2025 — Nov 2025 [monthly]

Recruiting NA
Jun 2025 — Sep 2025 [monthly]

Recruiting NA
Feb 2025 — Jun 2025 [monthly]

Recruiting NA
Sep 2024 — Feb 2025 [monthly]

Recruiting NA

▶ Show 8 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2023 — Jul 2024 [monthly]

Recruiting NA
Nov 2022 — Oct 2023 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Oct 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Sep 2018 — Oct 2020 [monthly]

Recruiting NA
Jun 2018 — Sep 2018 [monthly]

Recruiting NA
Jun 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Cancer Society (CCS)
McMaster University
Prostate Cancer Canada

Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Augusta, United States , Barueri, Brazil , Belo Horizonte, Brazil , Bogotá, Colombia , Botucatu, Brazil , Bragança Paulista, Brazil , Brasília, Brazil , Cali, Colombia , Campina Grande do Sul, Brazil and 29 more locations